JAFRAL Connected with the Global Phage Community at VoM 2026

JAFRAL participated in Viruses of Microbes (VoM) 2026 in Prague, joining researchers, innovators, and industry experts from around the world to discuss the future of phage therapy.

During the event, the team showcased JAFRAL’s capabilities in bacteriophage development and manufacturing, including process development, scale-up, GMP production, and regulatory support. Visitors had the opportunity to meet CEO Frenk Smrekar and Head of GMP Process & Product Development Janja Kozjek, and learn more about JAFRAL’s expertise in bringing phage therapies from research to clinical application.

VoM 2026 provided a valuable opportunity to exchange knowledge, strengthen partnerships, and connect with the global phage community as JAFRAL continues to support the development of innovative bacteriophage therapies.

‍